Literature DB >> 1778991

Three types of mouse peptidylarginine deiminase: characterization and tissue distribution.

H Terakawa1, H Takahara, K Sugawara.   

Abstract

Three types of mouse peptidylarginine deiminase were separated by DEAE-Sephacel ion-exchange column chromatography, and we propose designating them peptidylarginine deiminase type I, II, and III according to the order of elution. The type II enzyme was widely distributed in various tissues including the skeletal muscle, whereas the type I enzyme was localized in the epidermis and uterus, and the type III enzyme was detected in the epidermis and hair follicles. These enzymes were distinguished by their molecular weights and substrate specificity. The molecular weights were estimated to be approximately 54,000 (type I) and 100,000 (type II and III) by Sephacryl S-200 gel filtration column chromatography. On SDS-PAGE the type II and III enzymes gave Mr = 81,000 and Mr = 76,000, respectively. Among the substrates tested, the type I enzyme showed highest activity toward BZ-L-Arg-NH2, type II toward BZ-L-Arg-O-Et, and type III toward protamine. Western blot analysis showed that antibodies against the type II enzyme were immuno-crossreactive to the type III enzyme.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1778991     DOI: 10.1093/oxfordjournals.jbchem.a123636

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  15 in total

1.  cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I.

Authors:  Marina Guerrin; Akihito Ishigami; Marie-Claire Méchin; Rachida Nachat; Séverine Valmary; Mireille Sebbag; Michel Simon; Tatsuo Senshu; Guy Serre
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

2.  Citrullination regulates the expression of insulin-like growth factor-binding protein 1 (IGFBP1) in ovine uterine luminal epithelial cells.

Authors:  Coleman H Young; Heather M Rothfuss; Philip F Gard; Aaron Muth; Paul R Thompson; Ryan L Ashley; Brian D Cherrington
Journal:  Reproduction       Date:  2016-10-10       Impact factor: 3.906

3.  NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes.

Authors:  Sijun Dong; Takuya Kanno; Ayako Yamaki; Toshio Kojima; Masakazu Shiraiwa; Akira Kawada; Marie-Claire Méchin; Stéphane Chavanas; Guy Serre; Michel Simon; Hidenari Takahara
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

4.  Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.

Authors:  Abdiwahab A Musse; Zhen Li; Cameron A Ackerley; Dorothee Bienzle; Helena Lei; Roberto Poma; George Harauz; Mario A Moscarello; Fabrizio G Mastronardi
Journal:  Dis Model Mech       Date:  2008-11-06       Impact factor: 5.758

5.  ATP induces protein arginine deiminase 2-dependent citrullination in mast cells through the P2X7 purinergic receptor.

Authors:  Sanja Arandjelovic; Katherine R McKenney; Sunamita S Leming; Kerri A Mowen
Journal:  J Immunol       Date:  2012-09-14       Impact factor: 5.422

Review 6.  Histone citrullination: a new target for tumors.

Authors:  Dongwei Zhu; Yue Zhang; Shengjun Wang
Journal:  Mol Cancer       Date:  2021-06-11       Impact factor: 27.401

Review 7.  Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.

Authors:  Mei-Ling Yang; Fernanda M C Sodré; Mark J Mamula; Lut Overbergh
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

8.  Progesterone stimulates histone citrullination to increase IGFBP1 expression in uterine cells.

Authors:  Coleman H Young; Bryce Snow; Stanley B DeVore; Adithya Mohandass; Venkatesh V Nemmara; Paul R Thompson; Baskaran Thyagarajan; Amy M Navratil; Brian D Cherrington
Journal:  Reproduction       Date:  2021-07-08       Impact factor: 3.906

Review 9.  PAD4 takes charge during neutrophil activation: Impact of PAD4 mediated NET formation on immune-mediated disease.

Authors:  Xiaosong Liu; Tom Arfman; Kanin Wichapong; Chris P M Reutelingsperger; Jan Voorberg; Gerry A F Nicolaes
Journal:  J Thromb Haemost       Date:  2021-05-12       Impact factor: 5.824

10.  Posttranslational Protein Modification in the Salivary Glands of Sjögren's Syndrome Patients.

Authors:  Rafael Herrera-Esparza; Mayra Rodríguez-Rodríguez; María Elena Pérez-Pérez; Martha Adriana Badillo-Soto; Felipe Torres-Del-Muro; Juan José Bollain-Y-Goytia; Deyanira Pacheco-Tovar; Esperanza Avalos-Díaz
Journal:  Autoimmune Dis       Date:  2013-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.